To The Moon

$ABF SG BOND ETF(A35.SI)$ bonds bringing the steady gains! SG yields peaking + Fed pivot coming makes this ETF a safe bet. Not huge returns but that sweet dividend drip never stops!

$YZJ Shipbldg SGD(BS6.SI)$ shipping those gains! Small win now but with global ship orders rebounding and LNG vessel boom, this baby's just getting started. SGX account making moves!

$Baidu(BIDU)$ is starting to flex those AI muscles! ERNIE 4.0 and Apollo looking juicy - this small gain just the appetizer. Holding for the main course when AI hype kicks in!

$MP Materials Corp.(MP)$ coming through with those rare earth gains! EV and wind energy boom means this baby's got legs. Small win now, but holding for that sweet policy catalyst to send it flying!

$T-Rex 2X Inverse NVIDIA Daily Target ETF(NVDQ)$ Playing NVDQ inverse ETF was a slick move! When NVDA $NVIDIA(NVDA)$ got overhyped, this bad boy delivered. Everyone knows AI chips need a reality check-keeping some dry powder for the next swing!

Coinbase's stock recently slumped 11% pre-market after reporting a Q2 2025 adjusted profit drop due to a 44% decline in trading volume from the prior quarter, reflecting lower crypto market volatility and trading activity. Despite this, the GENIUS Act, signed into law in July 2025, is a significant long-term catalyst for Coinbase. Here’s a breakdown of the future outlook for Coinbase in light of this legislation: Impact of the GENIUS ActThe GENIUS Act (Guiding and Establishing National Innovation for U.S. Stablecoins) establishes a federal framework for stablecoins, requiring full reserve backing, real-time redemption, and transparency standards. This is a pivotal moment for Coinbase, given its deep involvement with USD Coin (USDC), the second-largest stablecoin:Regulatory Clarity Boosts S

$Aurora Innovation(AUR)$ $Aurora Innovation(AUR)$ 💡 Bullish on AUR – The Future of Autonomous Driving I’ve been watching Aurora Innovation ($AUR) closely, and I’m seriously optimistic about its long-term growth. This isn’t just another EV hype stock — it’s a focused player in autonomous trucking technology, and they’re making steady real-world progress. 🔍 What they do: • Developing Aurora Driver, an autonomous driving system for freight trucks and commercial vehicles • Partnered with industry leaders like FedEx, Uber Freight, Volvo, and PACCAR • Targeting a scalable, driverless trucking solution in the coming years 💰 Financials & Cash Flow: • As of recent filings, $AUR has around $1 billion in cash on h

With AMD set to report earnings on August 5, and other Big Tech names continuing to release results throughout the month, investors are closely watching for signals of continued AI-driven capex expansion, a key driver for both AMD and Nvidia. --- 🏗️ Will Big Tech Increase Capex? The trend suggests: yes, but more selectively. AI infrastructure remains a top priority, particularly in cloud (e.g., AWS, Azure, Google Cloud), where demand for GPUs and AI accelerators remains robust. Capex growth is likely to continue at firms building proprietary LLMs, expanding data centres, or enhancing inference capacity. However, non-AI capex may flatten or decline, as companies tighten costs in slower-growth segments. In short, AI-related capex will stay elevated, which supports both Nvidia and AMD demand

$Novo-Nordisk A/S(NVO)$  🚀 $NVO – The Next Mega Growth Story in Healthcare? 💉📈 Novo Nordisk ($NVO), the global leader in diabetes and obesity care, is shaping up to be one of the most powerful growth stocks in the healthcare sector — much like how Meta ($META) revolutionized social media, NVO is transforming health and longevity. 🔹 Financials That Inspire Confidence ✅ Revenue (Q2 2025): ~$9.6B (YoY growth of 30%+) ✅ Operating profit margin: Over 45% ✅ Net profit: Rising consistently, backed by surging demand for Ozempic and Wegovy ✅ Market cap: $550B+ and climbing ✅ Free cash flow: Strong and stable — supports innovation and shareholder returns 🔹 Why the Bullish Momentum? 💊 Explosive global demand for GLP-1 drugs (Oze

🌟🌟🌟OCBC $ocbc bank(O39.SI)$  Q2 25 report reminded us why this bank is more than just another blue chip name.  Amid margin pressures and global headwinds, it delivered solid beats on profit and showcased growth in fee income, all while reaffirming a generous dividend that anchors investor confidence. Q2 25 Earnings Highlights  Net profit of SGD 1.82 billion was down YoY but topped consensus estimates by 2%. Net interest income slipped 6% to SGD 2.28 billion as NIM narrowed to 1.92%.  However Management still targets 1.90% to 1.95% for 2025. Non interest income jumped 5%, led by wealth management fees as Assets Under Management hit a record SGD 310 billion, an increase of 11%. Asset quality

The Q2 2025 earnings season has been a wild ride, and semiconductor giants ARM Holdings (ARM) and Qualcomm ( $Qualcomm(QCOM)$ ) have added fuel to the fire with results that sparked sharp market reactions. ARM’s shares slid over 8% after disappointing smartphone royalties overshadowed an otherwise solid earnings report, while Qualcomm, despite beating Wall Street expectations, saw its stock dip in extended trading due to a cautious Q4 outlook. With the S&P 500 at 6,297.36 and Nasdaq at 20,884.27, both at record highs, the market’s high expectations and a VIX at 15.94 signal volatility. Were ARM and Qualcomm’s earnings “not good enough” to sustain their momentum, or is this a buying opportunity in disguise? This deep dive explores their financi

**Factors Driving Palantir Technologies (PLTR) Stock Price Fluctuations in 2025** Palantir Technologies (PLTR), a leader in big data analytics and AI, has experienced significant stock price volatility since its 2020 direct listing, with its share price soaring to $154.27 as of August 1, 2025, a 73% year-to-date increase and a 1,600%+ rise since 2023 lows. This volatility is driven by a combination of company-specific, market, and external factors, amplified by Palantir’s unique position in AI, defense, and commercial sectors. Below is an analysis of the key drivers of PLTR’s stock price fluctuations in 2025, incorporating real-time financial data and broader market context. ### **1. Strong Financial Performance and Growth Metrics** Palantir’s robust financial results have been a primary d

Coinbase’s latest earnings sent a chill through crypto markets—and for good reason. The headline numbers tell a mixed story: yes, revenue grew 3.4% year-on-year, but the sequential (QoQ) decline was a steep 26%. Most worrying, core revenue from trading—a critical pillar for Coinbase’s business—fell well short of expectations. The market punished the miss with a swift 9% drop in the stock, and it’s not hard to see why: after a strong first quarter powered by resurgent crypto activity, a sudden trading volume slump suggests the business is far more cyclical and less robust than some bulls hoped. The reliance on investment gains, especially the $1.5 billion in unrealized gains from Circle, should absolutely be a red flag for investors who care about the health of the core business. While GAAP

This earnings season has been brutal for chip stocks, and the latest results from ARM and Qualcomm only reinforce the new reality: “beats” aren’t enough when investors want big upside and clear growth acceleration. ARM’s shares slipped after its earnings as smartphone royalty revenue disappointed. Despite strong ambitions in AI and data center chips, ARM is still heavily dependent on the smartphone market, which remains sluggish. Investors wanted to see a sharp turnaround or at least outsized growth in new areas to offset the mobile softness—but instead got a reminder that legacy revenue streams still matter. It’s a classic case of the market punishing even slight weakness in key segments, especially when the valuation is already high. Qualcomm, for its part, actually beat expectations and

This earnings season is a minefield—markets at all-time highs, but the reaction to results is unforgiving. As Goldman Sachs points out, it’s classic “negative asymmetry”: good news gets a shrug, but a miss triggers a cliff-dive. In this kind of environment, risk management isn’t just smart, it’s essential if you want to survive—and thrive. How do you hedge risks when the market feels this stretched? 1. Options as Insurance: The simplest way to protect gains at market highs is buying puts—either on the stocks you own or on broad indices like the S&P 500 (SPY) or Nasdaq (QQQ). Yes, it costs money (like buying insurance), but when a bad earnings print hits and a stock drops 10–15% overnight, those puts suddenly look genius. 2. The Iron Condor for Earnings Volatility: When implied volatili

OCBC’s Q2 results are a classic “glass half full” story in this earnings season. Yes, profit fell 7% year-on-year to S$1.82 billion, but the number still came in ahead of consensus expectations (S$1.79 billion). In a market where investors have braced for margin pressure and weaker results across Singapore banks, an earnings beat—even on declining profit—lands as a minor win. The healthy dividend of S$0.41 per share adds another layer of reassurance for income-focused shareholders. The bigger question is whether DBS and UOB can repeat the trick. Like OCBC, both are battling headwinds from declining net interest margins (NIM), rising funding costs, and an increasingly competitive loan market. However, OCBC’s ability to beat even cautious forecasts suggests that cost control, stable fee inco